tiprankstipranks
Cartesian Therapeutics (RNAC)
NASDAQ:RNAC
US Market
RNAC
Cartesian Therapeutics
RESEARCH TOOLSreports
Want to see RNAC full AI Analyst Report?

Cartesian Therapeutics (RNAC) Ratios

1,206 Followers

Cartesian Therapeutics Ratios

RNAC's free cash flow for Q2 2026 was $0.00. For the 2026 fiscal year, RNAC's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 7.48 8.65 9.43 1.33 5.91
Quick Ratio
 7.48 8.65 9.43 1.33 5.91
Cash Ratio
 7.18 8.38 9.25 1.13 4.24
Solvency Ratio
 -0.34 -0.30 -0.17 -0.29 0.52
Operating Cash Flow Ratio
 -3.70 -4.95 -1.03 -0.75 -1.26
Short-Term Operating Cash Flow Coverage
 0.00 -17.81 0.00 0.00 -3.73
Net Current Asset Value
$ -290.24M$ -293.38M$ -225.20M$ -654.50M$ 76.08M
Leverage Ratios
Debt-to-Assets Ratio
 0.20 0.04 0.03 0.04 0.23
Debt-to-Equity Ratio
 -0.51 -0.10 -2.06 -0.02 0.40
Debt-to-Capital Ratio
 -1.04 -0.11 1.95 -0.03 0.29
Long-Term Debt-to-Capital Ratio
 -0.73 0.00 0.00 0.00 0.16
Financial Leverage Ratio
 -2.54 -2.35 -63.96 -0.69 1.77
Debt Service Coverage Ratio
 -174.19 -30.68 0.00 -76.26 3.51
Interest Coverage Ratio
 -115.80 0.00 0.00 -30.50 4.80
Debt to Market Cap
 0.22 0.02 0.00 0.00 0.19
Interest Debt Per Share
 2.20 0.49 0.54 2.67 10.19
Net Debt to EBITDA
 0.53 0.82 2.61 0.28 -1.72
Profitability Margins
Gross Profit Margin
-766.42%100.00%100.00%100.00%98.16%
EBIT Margin
-10848.48%-4987.31%-198.23%-907.08%34.12%
EBITDA Margin
-10670.48%-4881.52%-195.27%-903.84%35.96%
Operating Profit Margin
-6679.69%-3099.93%-112.81%-332.32%13.12%
Pretax Profit Margin
-10906.16%-4987.31%-198.23%-917.97%31.39%
Net Profit Margin
-10422.48%-4658.63%-198.97%-844.91%31.94%
Continuous Operations Profit Margin
-10283.75%-4658.63%-198.97%-844.91%31.94%
Net Income Per EBT
95.57%93.41%100.37%92.04%101.75%
EBT Per EBIT
163.27%160.88%175.72%276.23%239.17%
Return on Assets (ROA)
-48.31%-43.96%-17.80%-72.02%21.33%
Return on Equity (ROE)
141.41%103.22%1138.25%49.91%37.71%
Return on Capital Employed (ROCE)
-33.10%-30.80%-10.65%-36.49%10.32%
Return on Invested Capital (ROIC)
-30.78%-28.36%-10.58%-33.28%9.63%
Return on Tangible Assets
-87.19%-52.49%-32.77%-206.71%21.33%
Earnings Yield
-63.79%-69.58%-16.69%-216.15%25.95%
Efficiency Ratios
Receivables Turnover
 7.54 2.51 44.63 2.94 11.24
Payables Turnover
 12.23 0.00 0.00 0.00 6.45
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.09 0.16 2.52 2.13 7.69
Asset Turnover
 <0.01 <0.01 0.09 0.09 0.67
Working Capital Turnover Ratio
 0.01 0.02 0.36 0.36 1.13
Cash Conversion Cycle
 18.60 145.50 8.18 124.24 -24.14
Days of Sales Outstanding
 48.44 145.50 8.18 124.24 32.48
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 29.83 0.00 0.00 0.00 56.62
Operating Cycle
 48.44 145.50 8.18 124.24 32.48
Cash Flow Ratios
Operating Cash Flow Per Share
 -2.58 -2.85 -0.91 -9.90 -7.87
Free Cash Flow Per Share
 -2.65 -3.06 -1.26 -9.93 -8.16
CapEx Per Share
 0.07 0.21 0.35 0.04 0.30
Free Cash Flow to Operating Cash Flow
 1.03 1.07 1.38 1.00 1.04
Dividend Paid and CapEx Coverage Ratio
 -36.52 -13.56 -2.60 -248.35 -26.34
Capital Expenditure Coverage Ratio
 -36.52 -13.56 -2.60 -248.35 -26.34
Operating Cash Flow Coverage Ratio
 -1.19 -5.83 -1.69 -4.67 -0.83
Operating Cash Flow to Sales Ratio
 -51.51 -26.44 -0.61 -1.97 -0.29
Free Cash Flow Yield
-32.48%-42.40%-7.06%-50.53%-24.09%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.38 -1.44 -5.99 -0.46 3.85
Price-to-Sales (P/S) Ratio
 162.92 66.95 11.92 3.91 1.23
Price-to-Book (P/B) Ratio
 -1.93 -1.48 -68.21 -0.23 1.45
Price-to-Free Cash Flow (P/FCF) Ratio
 -3.08 -2.36 -14.16 -1.98 -4.15
Price-to-Operating Cash Flow Ratio
 -3.17 -2.53 -19.60 -1.99 -4.31
Price-to-Earnings Growth (PEG) Ratio
 <0.01 -0.03 0.06 <0.01 -0.02
Price-to-Fair Value
 -1.93 -1.48 -68.21 -0.23 1.45
Enterprise Value Multiple
 -1.00 -0.55 -3.49 -0.15 1.70
Enterprise Value
 156.88M 74.80M 265.33M 35.69M 67.80M
EV to EBITDA
 -1.00 -0.55 -3.49 -0.15 1.70
EV to Sales
 106.22 26.74 6.82 1.37 0.61
EV to Free Cash Flow
 -2.01 -0.94 -8.10 -0.69 -2.07
EV to Operating Cash Flow
 -2.06 -1.01 -11.21 -0.70 -2.14
Tangible Book Value Per Share
 -9.07 -6.71 -7.94 -123.58 23.33
Shareholders’ Equity Per Share
 -4.25 -4.86 -0.26 -85.14 23.33
Tax and Other Ratios
Effective Tax Rate
 0.06 0.07 >-0.01 0.08 -0.02
Revenue Per Share
 0.05 0.11 1.50 5.03 27.55
Net Income Per Share
 -5.22 -5.02 -2.99 -42.49 8.80
Tax Burden
 0.96 0.93 1.00 0.92 1.02
Interest Burden
 1.01 1.00 1.00 1.01 0.92
Research & Development to Revenue
 46.30 20.75 1.16 2.74 0.65
SG&A to Revenue
 21.50 11.25 0.77 1.56 0.22
Stock-Based Compensation to Revenue
 6.26 3.76 0.17 0.87 0.10
Income Quality
 0.50 0.57 0.31 0.23 -0.89
Currency in USD